PRGO
66
9
D
33
-4
URBN
70
7
HCA
35
-9
ETN
87
4
OKE
71
-3
VLO
33
-2
IR
83
3
VRTX
58
-2
ROP
54
-6
SHW
58
12
AKAM
45
2
GOOG
97
14
DFS
64
2
MU
54
6
CNP
47
-3
NOC
47
-6
HOG
33
6
FOX
33
-6
FCX
56
2
PRGO
66
9
D
33
-4
URBN
70
7
HCA
35
-9
ETN
87
4
OKE
71
-3
VLO
33
-2
IR
83
3
VRTX
58
-2
ROP
54
-6
SHW
58
12
AKAM
45
2
GOOG
97
14
DFS
64
2
MU
54
6
CNP
47
-3
NOC
47
-6
HOG
33
6
FOX
33
-6
FCX
56
2
Financhill
Back

Ultragenyx Pharmaceutical Quote, Financials, Valuation and Earnings

Elon's Secret "A.I. 2.0" Project

Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
44.21
Seasonality Move:
10.8%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

Ultragenyx Pharmaceutical Price Quote

$44.21
-0.03 (0.82%)
(Updated: April 27, 2024 at 6:18 AM ET)

Ultragenyx Pharmaceutical Key Stats

Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell
Day range:
$43.71 - $44.58
52-week range:
$31.52 - $54.98
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.49
P/B ratio:
13.23%
Volume:
450.4K
Avg. volume:
712.5K
1-year change:
4.51%
Market cap:
$3.6B
Revenue:
$434.2M
EPS:
$-8.33

How Much Does Ultragenyx Pharmaceutical Make?

Is Ultragenyx Pharmaceutical Growing As A Company?

Ultragenyx Pharmaceutical Stock Price Performance

What Is Ultragenyx Pharmaceutical 52-Week High & Low?

Ultragenyx Pharmaceutical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ultragenyx Pharmaceutical?

Is Ultragenyx Pharmaceutical Cash Flow Positive?

  • What Is RARE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$474.8M
  • What Is Ultragenyx Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $388.1M
  • What Is Ultragenyx Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $168M

Ultragenyx Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    RARE return on invested capital is -300.57%
  • What Is Ultragenyx Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is -43.52%
  • What Is RARE Return On Equity?
    ROE is a measure of profitability and is -300.57%

Ultragenyx Pharmaceutical Earnings Date & Stock Price

Ultragenyx Pharmaceutical Competitors

Ultragenyx Pharmaceutical Dividend Yield

Data Unavailable

Ultragenyx Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 5.73%
Revenue: 23.27% 5.29%

Analyst Recommendations

Buy Recommendations: 13
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 89.52
Upside from Last Price: 102.36%

Major Shareholders

  • How many RARE shares are owned by institutional investors?
    129.7M RARE shares are owned by institutional investors
  • How many RARE shares are owned by insiders?
    1.8M RARE shares are owned by insiders